Skip to main content
ACTRIS will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 to check if you are unsure if something is a scam or visit ScamShield (opens in new tab) for more information.

Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)

Developing foetal Mesenchymal Stem Cells (fMSC) for Therapies by Prof Jerry Chan

Topics

Webinars

24 August 2022

Watch this lecture exploring how primitive foetal stem cells are being developed for clinical use, and what makes them more capable than adult stem cells.

ACTRIS webinar flyer on foetal mesenchymal stem cells, Aug 24, 12-1PM, speaker Prof Jerry Chan.

Primitive foetal mesenchymal stem cells (fMSC) hold unique characteristics that differ from their adult counterparts.

They have a higher capacity to expand without senescence, and do not form tumours in xenograft models. In addition, they have an expanded repertoire for directed differentiation.

This lecture will delve into the translation journey of developing fMSC for pre- and post-natal clinical applications.

Thumbnail for YouTube video player